百诚医药：公司自主研发的智药AI平台，可应用于毒性预测以及活性和成药性预测

Core Viewpoint - The company has developed an AI platform for drug research that enhances the precision and efficiency of drug development processes [2] Group 1: AI Platform - The AI platform, referred to as the "Smart Drug AI Platform," is capable of predicting toxicity, activity, and drug-likeness [2] - This platform aims to improve the accuracy and efficiency of drug development [2] Group 2: New Drug Department - The new drug department utilizes an organoid platform that offers drug screening, efficacy evaluation, and safety assessment services [2] - These services are designed to support more precise and efficient drug research [2]